| CESTRATA AMGEN INC.
1830767 03 Apr 2017 | on 26 Sep 2019 | Class 005 Class 005 Pharmaceutical Products Pharmaceutical preparations for use in the treatment of cancer, malignant tumours and for suppressing tumors; pharmaceutical preparations for use in the treatment of autoimmune diseases, inflammation, inflammatory diseases and disorders, neurologic diseases and disorders, namely, brain injury, spinal cord injury, seizure disorders, mood disorders, anxiety disorders, cognitive disorders, schizophrenia, and neuromuscular diseases and disorders, namely, cerebrovascular accident (stroke), Parkinson's disease, multiple sclerosis, myasthenia gravis and Huntington's disease; pharmaceutical preparations for use in the treatment of metabolic diseases and disorders, namely diabetes, hypoglycaemia, gout, osteoarthritis, muscular dystrophy, anemia; and pharmaceutical preparations for use in the treatment of cardiovascular diseases and disorders. | | | CESTRATA AMGEN INC.
1408943 28 Aug 2008 | on 17 Sep 2014 | Class 005 Class 005 Pharmaceutical Products Pharmaceutical preparations for use in the treatment of oncological diseases and disorders. | | 
